1. Home
  2. CYTK vs RRX Comparison

CYTK vs RRX Comparison

Compare CYTK & RRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$68.45

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Regal Rexnord Corporation

RRX

Regal Rexnord Corporation

HOLD

Current Price

$146.32

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
RRX
Founded
1997
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.0B
IPO Year
2004
1987

Fundamental Metrics

Financial Performance
Metric
CYTK
RRX
Price
$68.45
$146.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
10
Target Price
$77.87
$173.80
AVG Volume (30 Days)
1.9M
890.8K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
0.96%
EPS Growth
N/A
22.48
EPS
N/A
3.87
Revenue
$87,211,000.00
$5,872,300,000.00
Revenue This Year
$363.61
N/A
Revenue Next Year
$64.33
$3.78
P/E Ratio
N/A
$37.73
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$90.56
52 Week High
$69.33
$177.48

Technical Indicators

Market Signals
Indicator
CYTK
RRX
Relative Strength Index (RSI) 62.93 57.71
Support Level $59.85 $128.45
Resistance Level $67.98 $149.18
Average True Range (ATR) 2.72 6.05
MACD 0.13 1.71
Stochastic Oscillator 91.35 82.23

Price Performance

Historical Comparison
CYTK
RRX

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About RRX Regal Rexnord Corporation

Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.

Share on Social Networks: